Andrew D. Lipman - 28 May 2024 Form 4 Insider Report for NU SKIN ENTERPRISES, INC. (NUS)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
28 May 2024, 18:18:22 UTC
Prior SEC filing
25 Apr 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ Gregory Belliston as Attorney-in-Fact for Andrew D. Lipman

Key filing fact

Andrew D. Lipman filed Form 4 for NU SKIN ENTERPRISES, INC. (NUS) on 28 May 2024.

Key facts

  • This page summarizes Andrew D. Lipman's Form 4 filing for NU SKIN ENTERPRISES, INC. (NUS).
  • 1 reported transaction and 0 derivative rows are listed below.
  • Accepted by SEC: 28 May 2024, 18:18.

Change

  • Previous filing in this sequence was filed on 25 Apr 2024.
  • Current net transaction value: -$26,660.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

NUS transaction

Class A Common Stock

Sale

Transaction value
$26,660
Shares
-2,000
Change %
-7.9%
Price
$13.33
Shares after
23,225
Date
28 May 2024
Ownership
Direct
Footnotes
F1
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Sale pursuant to a plan that was intended to comply with the prior version of Rule 10b5-1.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .